Natixis Advisors LLC Has $19.73 Million Stock Position in Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• Natixis Advisors LLC increased its stake in Haleon PLC by 25.5% during the first quarter, reaching a total holding of 1,917,548 shares valued at approximately $19.73 million.
• Several institutional investors have also raised their positions in Haleon, with Holistic Financial Partners growing its stake by 9.6% during the same period.
• Wall Street analysts have upgraded Haleon’s ratings, with firms like BNP Paribas now rating it as an "outperform" and projecting a price target of $13.40 for the stock.

Natixis Advisors LLC lifted its holdings in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 25.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,917,548 shares of the company's stock after purchasing an additional 390,156 shares during the period. Natixis Advisors LLC's holdings in Haleon were worth $19,731,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of HLN. Farther Finance Advisors LLC boosted its position in shares of Haleon by 8.8% in the first quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock valued at $131,000 after acquiring an additional 1,041 shares during the period. Apollon Wealth Management LLC raised its stake in Haleon by 5.4% during the 1st quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company's stock valued at $224,000 after purchasing an additional 1,111 shares during the last quarter. Simplicity Wealth LLC boosted its holdings in Haleon by 7.9% in the 1st quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock valued at $159,000 after purchasing an additional 1,135 shares during the period. Holistic Financial Partners grew its position in Haleon by 9.6% in the 1st quarter. Holistic Financial Partners now owns 13,379 shares of the company's stock worth $138,000 after purchasing an additional 1,172 shares during the last quarter. Finally, AE Wealth Management LLC grew its position in Haleon by 6.5% in the 1st quarter. AE Wealth Management LLC now owns 19,323 shares of the company's stock worth $199,000 after purchasing an additional 1,186 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Stock Up 2.5%

NYSE HLN opened at $9.67 on Friday. Haleon PLC Sponsored ADR has a 1-year low of $8.86 and a 1-year high of $11.42. The company has a market capitalization of $43.44 billion, a price-to-earnings ratio of 24.80, a PEG ratio of 2.79 and a beta of 0.23. The stock's 50 day moving average is $10.37 and its two-hundred day moving average is $10.19. The company has a current ratio of 0.98, a quick ratio of 0.78 and a debt-to-equity ratio of 0.53.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HLN. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective for the company in a research report on Tuesday, May 27th. Wall Street Zen cut Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Morgan Stanley raised Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a report on Friday, May 9th. BNP Paribas upgraded Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Finally, Barclays restated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, four have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.